# Ontario Bioscience Industry Organization

> Ontario Bioscience Industry Organization is a VC fund backing Biotechnology. See 5 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Toronto, Canada
- Total investments: 5
- Last investment: Mar 2026
- Lead investor: 40%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/10881097/
- X (Twitter): https://www.twitter.com/obioscience
- Website: http://obio.ca/

Ontario Bioscience Industry Organization is a VC fund in Toronto focused on Biotechnology and Biopharma. The Ontario Bioscience Industry Organization (OBIO) is a private sector.

## Contacts

5 contacts available for Ontario Bioscience Industry Organization. Shizune tracks 2 team members at Ontario Bioscience Industry Organization. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/ontario-bioscience-industry-organization?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 3 | 60% |
| Biopharma | 2 | 40% |
| Medical Device | 2 | 40% |
| Health Care | 1 | 20% |
| Life Science | 1 | 20% |

9 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 3 | 60% |
| Grant | 1 | 20% |
| Pre-Seed | 1 | 20% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Colin Foster | Ontario Bioscience Innovation Organization - CAAP Committee Member | 0 | https://shizune.co/investors/profile/colin-j-foster |
| Paul Santaguida | Consultant | 0 | https://shizune.co/investors/profile/paul-santaguida |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Block Biosciences | Block Biosciences is a life‑sciences startup that develops small‑molecule therapeutics aimed at blocking the spread of cancer to the brain. The company works on inhibiting specific metabolic pathways that cancer cells use to initiate brain metastases, using predictive models and targeted drug design. It also explores companion‑diagnostic‑type toolsto help identify patients at high risk for brain spread. | $73.1K | Pre-Seed | Mar 05, 2026 |  |
| HDAX Therapeutics | HDAX Therapeutics is pioneering next-gen precision therapeutics for cardiovascular and neurological diseases by targeting their root causes to enhance patient outcomes. | $3.2M | Seed | Sep 05, 2024 |  |
| Tenomix | Tenomix mission is to develop novel technologies that target inefficiencies in the pathology workflow optimize cancer care and reduce healthcare costs | $1.6M | Seed | Mar 01, 2024 |  |
| Qidni Labs | Over two million patients around the world suffer from End Stage Renal Disease (ESRD). Patients' survival depends on dialysis, a renal replacement therapy that they undergo until they receive a kidney transplant. The survival rate of patients under dialysis is less than 40% in 5 years (1).A year of dialysis of each patient may cost upwardsof $60,000 in Canada and the United States. Patients endure a lot more hardships due to complications and lifestyle restrictions. Studies show that longer treatment times can potentially be associated with prolonged survival. |  | Grant | Jul 27, 2021 |  |
| AmacaThera | AmacaThera is a clinical-stage company based in Toronto. AmacaThera is redefining how therapeutics are delivered. AmacaThera has developed a platform hydrogel technology that addresses the critical problem of sustaining therapeutic delivery of pharmacological agents for multiple disease areas. AmacaThera’s lead product addresses post-operative painand consequently may have an impact on the opioid crisis. |  | Seed | Jan 01, 2016 |  |

5 of 5 investments shown.

## Co-investors
- [FACIT](https://shizune.co/investors/profile/facit-prospects-oncology-fund) — VC Fund, 3 deals together
- [Toronto Innovation Acceleration Partners](https://shizune.co/investors/profile/mars-innovation-mi) — VC Fund, 2 deals together
- [Ontario Centre of Innovation](https://shizune.co/investors/profile/oci-e51e) — VC Fund, 2 deals together
- [Anges Quebec](https://shizune.co/investors/profile/anges-quebec) — VC Fund, 1 deal together
- [Creative Destruction Lab](https://shizune.co/investors/profile/creative-destruction-lab) — VC Fund, 1 deal together
- [Eos BioInnovation](https://shizune.co/investors/profile/eos-bioinnovation) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Ontario Bioscience Industry Organization invest in?

Ontario Bioscience Industry Organization invests primarily in Biotechnology, Biopharma and Medical Device startups, most often at Seed and Grant stage. Most of the 5 investments tracked by Shizune back companies in Canada. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Ontario Bioscience Industry Organization?

Public channels for Ontario Bioscience Industry Organization include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Ontario Bioscience Industry Organization?

The team at Ontario Bioscience Industry Organization includes Colin Foster (Ontario Bioscience Innovation Organization - CAAP Committee Member) and Paul Santaguida (Consultant). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co